YAP1 and cancer: A proteomic screen using YAP-2L and YAP-C343A or TAZ and TAZ-3CA may identify novel cysteine-specific binding partners of YAP2L and TAZ and will provide a more comprehensive understanding the roles of YAP2L and TAZ in cancers in the future.